D-0651-2020 Class II Terminated

Recalled by Asclemed USA Inc. Dba Enovachem Pharmaceuticals — Torrance, CA

FDA drug recall D-0651-2020 was initiated by Asclemed USA Inc. Dba Enovachem Pharmaceuticals on Dec 9, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results. The recall status is terminated (terminated Aug 9, 2023). Affected quantity: 42.12 gm.

Recall details

Product Type
Drugs
Report Date
Jan 15, 2020
Initiation Date
Dec 9, 2019
Termination Date
Aug 9, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
42.12 gm

Product description

Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37

Reason for recall

Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.

Distribution pattern

Product was distributed to 6 physician's offices within the state of California.

Code information

Lot Code/Exp. Date: 11061901, 11061803, 11281804, 11291804, 04171902, 05201901, 08121902, EXP 12/31/2020; 08161901, 10111903, EXP 5/31/2021; 11211904, 10161901, EXP 8/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0651-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0651-2020. Report a data issue: hello@regdatalab.com.